CEO David Garrett invited to speak at TedX Sydney

Congratulations David! With ten years of innovation in medical device technology, – particularly in novel materials for neural interface applications – A/Prof (and CEO) David Garrett is an internationally regarded research scientist invested in developing high-performance electrodes for use inside

Read More »

BioMedTech Horizons Grant Awarded to Carbon Cybernetics

BioMedTech Horizons grant to develop a miniaturised neural implant The Australian Government is investing $18.8 million to boost efforts towards finding  better treatments for cancer, epilepsy, stroke, paralysis, Irritable Bowel Syndrome (IBS), brain injuries, back pain and other chronic diseases.

Read More »

New Publication in Nature

New publication in Nature Communications We are very pleased to announce that our latest research entitled “Critical slowing down as a biomarker for seizure susceptibility” has been published in the May issue of Nature communications.  The research explores the way

Read More »